Related Experiment Video
Updated: Jul 12, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia
S Panzer1, M Rieger, R Vormittag
1Clinic for Blood Group Serology, Medical University of Vienna, Vienna, Austria. simon.panzer@meduniwien.ac.at
European Journal of Clinical Investigation
|August 31, 2007
Summary
Platelet adhesion is linked to bleeding symptoms in chronic autoimmune thrombocytopenia (cAITP). Aggregate size reflects platelet activation, aiding in bleeding risk assessment for treatment decisions.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Chronic autoimmune thrombocytopenia (cAITP) is an immune-mediated disorder characterized by low platelet counts.
- Understanding platelet function is crucial for managing patients with cAITP and predicting bleeding risk.
Purpose of the Study:
- To investigate the association between platelet function parameters and hemorrhage in patients with cAITP.
- To explore the correlation of platelet P-selectin, adhesion, and aggregate formation with bleeding severity.
Main Methods:
- Evaluated platelet P-selectin expression, high shear-induced adhesion, and aggregate formation in 41 cAITP patients and 28 healthy controls.
- Correlated platelet function markers with a standardized bleeding score.
Main Results:
- cAITP patients exhibited higher P-selectin levels and reduced high shear-induced platelet adhesion compared to controls.
- Platelet adhesion and count were independently inversely correlated with bleeding symptoms.
- Aggregate size correlated with P-selectin levels, suggesting a link to in vivo platelet activation.
Conclusions:
- Platelet adhesion is a significant predictor of bleeding symptoms in cAITP.
- High shear aggregate size may indicate in vivo platelet activation.
- Assessing these platelet function parameters can aid in estimating bleeding risk and guiding treatment decisions.
More Related Videos
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...